Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line?

Clin Microbiol Infect. 2024 Mar;30(3):270-275. doi: 10.1016/j.cmi.2023.09.013. Epub 2023 Sep 22.

¹ Infectious Diseases Section, Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK, USA.
² Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
³ Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: rfchemaly@mdanderson.org.

No abstract available

Keywords: Cellular therapies; Clinical trials; Hematopoietic cell transplantation; Immunocompromised patients; Respiratory viral infections.

MeSH terms